Clarivate Analytics, the global leader in providing trusted insights and analytics to accelerate the pace of innovation, has joined Accenture's open partner ecosystem, which is designed to help independent software vendors (ISVs), specialised content providers, and life sciences companies team more effectively to advance drug discovery efforts and improve patient outcomes.
The ecosystem is an integral part of Accenture's cloud-based informatics research platform, which helps life sciences organisations improve productivity, efficiency and innovation in drug discovery. Clarivate is working with Accenture to integrate its content into Accenture's research platform and provide access to more robust insights that enable data-driven decision-making.
The data and intelligence provided by Cortellis, the life sciences suite of solutions from Clarivate, will be accessible to companies within a common informatics framework that addresses core infrastructure requirements such as data ingestion and cleansing, security and IP management, request management workflow, enterprise search, data governance, and collaboration environments. The scientifically-curated content in Cortellis includes more than 600,000 compounds, 2.3 million biological pathways and effects, comprehensive experimental results, clinical trial outcomes, and biomarkers intelligence. These rich data sets provide critical context for researchers and complement the data they generate in support of clinical research, regulatory, manufacturing, marketing and portfolio strategy needs.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
